Nuveen LLC Acquires Shares of 1,481,018 Teladoc Health, Inc. $TDOC

Key Points

• Nuveen LLC has acquired approximately 1.48 million shares of Teladoc Health, Inc. during the first quarter, valuing the investment at about $11.79 million, which represents a 0.84% stake in the company.
• Several large investors, including Cambridge Investment Research and Golden State Wealth Management, have significantly increased their holdings in Teladoc Health by over 60% in the first quarter.
• Analyst reports reflect a cautious outlook for Teladoc Health, with target price reductions from various financial institutions, leading to a consensus rating of "Hold" and an average price target of $9.75.

Nuveen LLC purchased a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,481,018 shares of the health services provider's stock, valued at approximately $11,789,000. Nuveen LLC owned 0.84% of Teladoc Health as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. boosted its position in Teladoc Health by 60.8% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider's stock valued at $316,000 after buying an additional 15,030 shares during the period. Golden State Wealth Management LLC boosted its position in Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after buying an additional 1,690 shares during the period. Wedmont Private Capital boosted its position in Teladoc Health by 20.3% in the 1st quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider's stock valued at $117,000 after buying an additional 2,715 shares during the period. Wealth Enhancement Advisory Services LLC boosted its position in Teladoc Health by 22.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider's stock valued at $134,000 after buying an additional 2,662 shares during the period. Finally, Vontobel Holding Ltd. boosted its position in Teladoc Health by 61.4% in the 1st quarter. Vontobel Holding Ltd. now owns 21,422 shares of the health services provider's stock valued at $171,000 after buying an additional 8,152 shares during the period. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Stock Up 2.0%

Shares of Teladoc Health stock traded up $0.16 during trading on Thursday, hitting $7.90. 3,908,711 shares of the stock were exchanged, compared to its average volume of 6,247,993. The stock has a market cap of $1.39 billion, a price-to-earnings ratio of -6.63 and a beta of 1.76. The firm's 50-day moving average price is $7.79 and its 200 day moving average price is $8.10. Teladoc Health, Inc. has a 12-month low of $6.35 and a 12-month high of $15.21. The company has a debt-to-equity ratio of 0.70, a current ratio of 2.67 and a quick ratio of 2.58.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings data on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.08. The business had revenue of $631.90 million during the quarter, compared to analysts' expectations of $621.91 million. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The company's revenue for the quarter was down 1.6% on a year-over-year basis. During the same period in the previous year, the company earned ($0.38) EPS. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. As a group, analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts have commented on TDOC shares. The Goldman Sachs Group decreased their price target on shares of Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, May 1st. Stifel Nicolaus decreased their price target on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating for the company in a research report on Thursday, May 1st. Evercore ISI raised their price target on shares of Teladoc Health from $7.00 to $8.00 and gave the company an "in-line" rating in a research report on Wednesday, July 9th. Wells Fargo & Company decreased their price objective on shares of Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating for the company in a research report on Thursday, May 8th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a research report on Thursday, May 1st. Six investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $9.80.

Insider Buying and Selling

In related news, insider Fernando M. Rodrigues sold 4,174 shares of Teladoc Health stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $6.91, for a total transaction of $28,842.34. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Adam C. Vandervoort sold 5,808 shares of Teladoc Health stock in a transaction on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total transaction of $39,842.88. Following the completion of the transaction, the insider owned 69,773 shares in the company, valued at approximately $478,642.78. This represents a 7.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 18,656 shares of company stock worth $128,189 in the last ninety days. 0.58% of the stock is owned by corporate insiders.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.